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Abstract
Background: Group A Streptococcus (GAS; Streptococcus pyogenes) causes a range of mild to severe infections in
humans. It can also colonize healthy persons asymptomatically. Therefore, it is important to study GAS carriage in
healthy populations, as carriage of it might lead to subsequent disease manifestation, clonal spread in the
community, and/or diversification of the organism. Throat swab culture is the gold standard method for GAS
detection. Advanced culture-independent methods provide rapid and efficient detection of microorganisms directly
from clinical samples. We investigated the presence of GAS in throat swab samples from healthy adults in Japan
using culture-dependent and culture-independent methods.
Results: Two throat swab samples were collected from 148 healthy volunteers. One was cultured on selective
medium, while total DNA extracted from the other was polymerase chain reaction (PCR) amplified with two
GAS-specific primer pairs: one was a newly designed 16S rRNA-specific primer pair, the other a previously described
V-Na+-ATPase primer pair. Although only 5 (3.4 %) of the 148 samples were GAS-positive by the culture-dependent
method, 146 (98.6 %) were positive for the presence of GAS DNA by the culture-independent method. To obtain
serotype information by emm typing, we performed nested PCR using newly designed emm primers. We detected
the four different emm types in 25 (16.9 %) samples, and these differed from the common emm types associated
with GAS associated diseases in Japan. The different emm types detected in the healthy volunteers indicate that the
presence of unique emm types might be associated with GAS carriage.
Conclusions: Our results suggest that culture-independent methods should be considered for profiling GAS in the
healthy hosts, with a view to obtaining better understanding of these organisms. The GAS-specific primers
(16S rRNA and V-Na+-ATPase) used in this study can be used to estimate the maximum potential GAS carriage in people.
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Background
Group A Streptococcus (GAS; Streptococcus pyogenes),
an extensively studied pathogen, causes mild and severe
human diseases [1]. As an exclusively human pathogen,
GAS is spread in the community through direct human-
to-human transmission. GAS can also colonize a healthy
host without any apparent clinical signs or symptoms
[2, 3]. It has been reported that the rate of asymptom-
atic GAS carriage is high in children (2.5–32 %) and low
in adults (1.5–4.9 %) [4–7]. Asymptomatic pathogen
presence in people might be associated with reduced
pathogen virulence and/or effective host immune re-
sponses against the pathogen [8]. The carriage state of
the pathogen might lead to subsequent disease mani-
festation [9] and/or its metabolic diversification to cope
with unfavorable conditions in the host such as harmful
pH or nutrient depletion [7]. Therefore, investigating
the GAS carriage state is a prerequisite for enhanced
understanding of the population biology of GAS in
terms of disease spread and pathogen survival in the
community.
In clinical microbiology, standard cultivation methods
are considered the ‘gold standard’ for microorganism de-
tection because the phenotypic characterization of clin-
ical isolates is important for determining the treatment
directions, but such methods are laborious and time-
consuming [10, 11]. Additionally, cultivation methods
often fail to detect pathogens present in different physio-
logical states such as viable but nonculturable (VBNC)
in host niches [11, 12]. In contrast, by employing nucleic
acid extracted directly from clinical samples, culture-
independent methods provide rapid results for bacteria
detection with high sensitivity and specificity [10, 11,
13, 14]. In particular, polymerase chain reaction
(PCR)-based methods using species-specific primers
targeting the 16S rRNA [15–21] or other conserved
genes [11, 22–26] are used widely for detecting micro-
organisms in the fields of clinical and environmental
microbiology.
The aim of the present study was to investigate the
presence of GAS in throat swab samples from healthy
adults in Japan using culture-dependent and culture-
independent methods. We designed new GAS-specific
16S rRNA and emm primers and investigated the GAS
carriage rate in swab samples from the throats of healthy
adults. The specificities of these primers were tested
against other Streptococcus species and their sensitivities
were evaluated by serial dilution of the DNA extracts
obtained from GAS cultures. The 16S rRNA primer pair
was used for specific PCR detection of GAS from human
throat swab samples in combination with the V-Na
+-ATPase primer pair reported previously [27], while the
newly designed emm primers were used to obtain emm
sequence information to check the GAS serotypes.
Methods
Study design
The ethical committee of Tokyo Medical and Dental
University approved this study. Throat swab samples
were collected from October 2013 to June 2014 from
students and staff from various departments in the Den-
tal Faculty of the Tokyo Medical and Dental University,
Tokyo, Japan (age range 20–60 years). All participants
were volunteers who provided informed consent. Partici-
pants were considered to be healthy if they lacked any
apparent clinical signs and symptoms such as sore throat
or cold for at least 2 weeks before sample collection.
Out of a total 165 participants, 17 with sore throat/
throat pain or any kind of infection for unknown rea-
sons were excluded from the final analysis (Additional
file 1: Table S1).
Sample collection
Two throat swabs were collected from the upper
pharyngeal region of each volunteer (n = 148). One swab
was dipped into 500 μl of sterile Trypticase soy broth
(TSB; BBL Microbiology Systems, Cockeysville, Md.) for
the culture-dependent study. The other swab was dipped
into 600 μl of the sterile bead solution from the Power-
Soil DNA isolation kit (MO BIO Laboratories, Carlsbad,
CA), mixed for 20–30 s, and the resultant solution was
stored at −80 °C prior to further extraction steps.
GAS-specific primers
To design the GAS-specific primers, the 16S rRNA se-
quences from Streptococcus spp. were obtained from the
Ribosomal Database Project (RDP) (http://rdp.cme.m-
su.edu/), and the potential PCR primer target regions
were manually determined using a Probe Match algo-
rithm. Among nine variable regions (V1–9) in the 16S
rRNA sequences, the hypervariable 2 (V2) region is
known to be one of the best target sequences for distin-
guishing Streptococcus spp. [15]. Therefore, we selected
the V2 region and designed GAS-specific primers based
on the alignment profiles made by a multiple sequence
alignment program (MAFFT) with default parameters
[28]. Primers for the putative sodium-V-ATPase subunit
B (V-Na+-ATPase) region, as described by Hung et al.
[27], was also used for GAS detection in the throat swab
samples. To obtain the emm-type information from the
total DNA extracted from the throat swabs, we adapted
the nested PCR strategy for the Vir regulon (virulence
regulon, recently referred to as Mga), which consists of a
tandemly linked family of M proteins genes such as fcrA,
emm, enn, scpA [29, 30]. vir primers, as described by
Gardiner et al. [29], were used for the primary nested
PCR. New emm primers were designed based on the
alignment profiles of the untrimmed emm sequences in
the Centers for Disease Control and Prevention (CDC)
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emm database (ftp://ftp.cdc.gov/pub/infectious_diseases/
biotech/emmsequ/) by MAFFT with the default param-
eter. The nucleotide sequences of all the primer pairs
are shown in Table 1.
Primer specificity and sensitivity
To evaluate the specificities of the selected primers, 11
GAS strains (isolated from pharyngitis infections in in-
fants with different GAS emm types) and 11 other non-
GAS Streptococcus strains (listed in Additional file 1:
Table S2) were incubated overnight in TSB at 37 °C.
Genomic DNA extraction was performed using a
DNeasy Blood and Tissue kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions, and the
concentration of the extracted DNA was quantified
using a Quant-iT PicoGreen dsDNA assay kit (Invitro-
gen, Carlsbad, USA). For primer specificity testing, PCR
was performed in a 20 μl volume containing 2 ng of
template DNA from the selected strains. S. pyogenes
JRS4 DNA and sterile deionized water were used as the
positive and negative controls, respectively. To check the
primer sensitivities, PCRs were performed using serially
diluted S. pyogenes JRS4 (M6) DNA with a concentration
range from 0.625 fg to 6.25 ng, which corresponds to
0.3 to 3 × 106 genome copies of GAS. All PCRs were
performed using MightyAmp DNA polymerase (Takara,
Tokyo, Japan).
GAS detection methods
Two methods, culture dependent and independent, were
used to detect GAS in throat swabs from healthy adults
(Fig. 1).
Culture-dependent study
For the culture-dependent method, swabs were streaked
onto the following two types of agar medium, supple-
mented with 5 % defibrinated sheep blood (Japan Biotest
Laboratories, Tokyo, Japan): Selective Strep Agar, Modi-
fied#2 (SSB) (Acumedia Manufacturers Inc., Baltimore,
MD) and Columbia-CNA agar (BD, Sparks, MD, USA).
In addition to streaking, each throat swab dipped TSB
broth was also added to 1.2 ml of fresh TSB for enrich-
ment. Enriched cultures were spread onto SSB agar
plates and incubated for a further 24 h. All cultivations
were carried at 37 °C under anaerobic conditions using
the AnaeroPack system (Mitsubishi Gas Chemical Co.,
Tokyo, Japan).
After 24 h incubation, colonies showing beta hemolysis
were selected randomly and checked for bacitracin sensi-
tivity by the disk diffusion method [2] using sterile paper
discs impregnated with 0.04 U Bacitracin (Nacalai Tesque,
Kyoto, Japan). Next, single colony lysates, prepared using
Lyse-N-Go PCR reagent (Thermo Scientific, Rockford,
IL, USA), were examined using GAS-specific 16S rRNA
and V-Na+−ATPase primers, and GAS serotyping was
performed using the CDC emm primers. The 25 μl PCR
mixtures each contained 2.5 μl of 10 X Ex Taq buffer,
2 μl of dNTPs, 2 μl of a 10 μM primer mix, 0.125 μl of
Ex Taq HS polymerase (Takara) and 1 μl of lysate. The
PCR conditions used are listed in Additional file 1:
Table S3.
Culture-independent study
Total DNA was extracted from each throat swab-dipped
bead solution using a PowerSoil DNA isolation kit (MO
BIO) with some modifications. Briefly, 500 mg of RNA
PowerSoil beads was added to the throat swab solution
and mixed thoroughly. In addition to 60 μl of solution
C1 from the kit, 450 μl of phenol:chloroform:isoamyl
alcohol (25:24:1) (Nacalai Tesque) was added to each
sample, and the rest of the procedure was performed
according to the manufacturer’s instructions. A 100 μl
aliquot of the extracted DNA solution was purified using
Ethachinmate (Wako, Tokyo, Japan), and the pellet was
then dissolved in 40 μl of Tris-EDTA buffer. The result-
ant samples were stored at −80 °C. The 50 μl PCR mix-
ture contained 25 μl of 2 X MightyAmp buffer Ver.2
(Takara), 4 μl of a 10 μM primer mix, 1 μl of Might-
yAmp DNA polymerase (Takara) and 5 μl of template
DNA. With the exception of the emm conserved PCR
Table 1 Primers used in this study






121 Hung et al. 2012 [27]
Vir SBR-AGACATGAGCGCAATGGCAAGTTTATCAAATGGTAATTTTTG
VUF-AAACCGTATCTTTGACGCACTCGAGGACAATTTGCGAGATTAG







Abbreviations: Fwd forward, Rev reverse, a CDC Centers for Disease Control and Prevention
For the SBR primer, G (shown in bold) replaces T in the original reference
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(2nd nested PCR), 0.5 μl of bovine serum albumin (New
England BioLabs, Beverly, MA, USA) and 5 μl of 5 M
Betaine (Sigma-Aldrich, St Louis, MO, USA) were added
to all other PCR mixtures. S. pyogenes JRS4 DNA and
sterile deionized water were used as the positive and
negative controls, respectively. The PCR conditions used
for each primer pair are listed in Additional file 1: Table
S3. PCR products were analyzed by electrophoresis on
2 % agarose gels with ethidium bromide staining.
For emm sequencing, 5 μl of each nested PCR product
was checked using agarose gel electrophoresis. After
confirmation of the desired amplicon, the remaining
PCR product was run on a 2 % agarose gel and stained
with SYBR safe DNA gel stain (Invitrogen). Amplicons
ranging from 800 to 2000 bp were extracted from gels
and purified using a NucleoSpin® Gel PCR Clean-Up kit
(Macherey-Nagel, Düren, Germany), and then cloned
into a pGEM-T vector (Promega, Medison, WI). The
cloned PCR products were sequenced using M13 primers
and the 3130 Genetic Analyzer (Applied Biosystems). The
sequences obtained were referred to the CDC database to
check the emm types (http://www2a.cdc.gov/ncidod/bio
tech/strepblast.asp).
Results
Primer sensitivity and specificity
We used species-specific primers for detection of GAS
from throat swab samples from healthy adults. The spec-
ificities of the 16S rRNA and V-Na+-ATPase primers
were evaluated initially using bacterial DNA extracted
from 11 different emm-type GAS strains and 11 other
streptococcal species. Both primer pairs showed positive
results for the GAS strains and did not cross-react with
the other non-target streptococcal species (Fig. 2). The
emm gene, which is a well-defined virulence GAS gene,
encodes an antiphagocytic surface determinant, and
emm typing is used widely in epidemiological surveil-
lance of GAS [31]. To acquire emm-type information
directly from the throat swabs, we designed new emm
primers for nested PCR to enhance the efficiency of the
subsequent analysis. However, nested emm PCR showed
limited specificity in the samples we tested (data not
shown). This result might be caused by cross reactivity
with other streptococcal species and/or human DNA in
the throat swab samples. The detection limit of all the
primers was examined using serially diluted S. pyogenes
JRS4 DNA (Fig. 3). Except for the V-Na+-ATPase
primers, 16S rRNA, vir and the new emm primers de-
tected 6.25 fg of GAS DNA. This result indicates that all
the primers have sufficiently high sensitivities to detect
even low abundance GAS populations in samples.
GAS isolation by culture-dependent methodology
Selective culture media were used for better isolation of
GAS from the swab samples. Additionally, we used strict
anaerobic conditions during culture for effective recovery
of GAS and for reducing aerobic commensal bacteria
loads [32–34]. Among the 148 samples, GAS was isolated
from five of them (3.4 %) (Fig. 4a). This rate is similar to
those of earlier GAS carriage reports in healthy adults
[6, 7]. All isolates were bacitracin sensitive and PCR posi-
tive using GAS-specific 16S rRNA and V-Na+-ATPase
Collection of two pharyngeal swab





Streak swab on GAS selective 
agar plates [*SSB , CCNB]
Enrichment
Screening of beta hemolytic colonies
Primary test: Bacitracin sensitivity
PCR confirmation by GAS-specific 16S rRNA 
and V-Na+-ATPase primer 
Dip swab in Trypticase-soy broth
Dip swab in bead solution
DNA extraction
DNA purification and elution
emm type detection by 
nested PCR (1st PCR: vir,
2nd PCR: emm conserved)
Anaerobic, 37 C
emm sequence typing 
by CDC primer
Sequence confirmation 
using CDC Blast 2.0 
Server
*SSB – selective strep blood agar, CCNB – Columbia-CNA blood agar
Fig. 1 Schematic representation of the strategy used for GAS detection from the throat swabs of healthy people
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primers. The emm types were analyzed by emm sequence
typing and by comparison with the sequences in the CDC
emm database: tmduSH - emm58.16, tmdu302 - emm81,
tmdu618 - emm28, tmdu1312-emm106, and tmdu1326 -
emm106.
GAS DNA detection by culture-independent methodology
Culture-independent molecular methods can detect mi-
croorganisms directly from DNA and RNA extracted
from environmental and clinical samples [19, 22, 23, 35].
We used a DNA-based PCR method to gain better
insight into the presence of GAS in healthy adults. As
described above and shown in Fig. 4a, GAS was isolated
in only 3.4 % of the samples by the culture-dependent
method. In contrast, of the 148 throat swabs, GAS DNA
was detected in 146 (98.6 %) samples using PCR with
both 16S rRNA and V-Na+-ATPase primer pairs (Fig. 4b).
To exclude the possibility of the primer sets cross-
reacting with other DNA sequences in vivo, the homolo-
gies of 50 random 16S rRNA and V-Na+-ATPase ampli-
con sequences were confirmed by BLAST analysis
against S. pyogenes. The 98.6 % detection rate is much
higher than those of conventional standard culture
methods. To determine the emm types, nested PCR
using emm-conserved region primer pairs was per-
formed following vir typing. Among the 146 samples,
the following emm types were identified in 25 of them
(16.9 %) by sequence analysis (Fig. 4b): emm58.16 (n = 13),
emm106.0 (n = 3), emm81.0 (n = 2), emm6.52 (n = 3), and
emm4.0 (n = 1) (Fig. 5, Additional file 1: Table S4).
Notably, three samples (n = 3) with both emm58.16
and emm6.52 were detected.
V-Na+-ATPase16S rRNA













Fig. 3 Primer sensitivity. Representative data for the detection limit of GAS-specific primers using MightyAmp DNA polymerase. S. pyogenes JRS4
DNA was serially diluted (6.25 ng to 0.625 fg DNA corresponds to 3 × 106 to 0.3 genomic copies of GAS). Sterile deionized water was used for the
negative control. Lane M, DNA marker; 1, 6.25 ng; 2, 625 pg; 3, 62.5 pg; 4, 6.25 pg; 5, 625 fg; 6, 62.5 fg; 7, 6.25 fg; 8, 0.625 fg; N, negative control.
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Fig. 2 Primer specificity. Representative results of PCRs using GAS-specific 16S rRNA and V-Na+-ATPase primers. DNA templates (2 ng) from 11
different GAS strains and 11 other Streptococcus species were used for primer specificity testing. S. pyogenes JRS4 DNA and sterile deionized water
were used for the positive and negative controls, respectively. Lane M, DNA marker; P, positive control; N, negative control; 1, emm1; 2, emm3; 3,
emm4; 4, emm6; 5, emm11; 6, emm12; 7, emm28; 8, emm58; 9, emm75; 10, emm87; 11, emm89; 12, S. salivarius; 13, S. sanguinis; 14, S. sobrinus; 15,
S. suis; 16, S. mutans; 17, S. pneumoniae; 18, S. mitis; 19, S. dysgalactiae; 20, S. constellatus; 21, S. intermedius; 22, S. anginosus
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Discussion
In clinical and environmental microbiology, rapid and
accurate identification of microorganisms is extremely
important. Amplification of 16S rRNA and other con-
served genes using species-specific primers has now
been established as a promising molecular detection
method. For rapid detection of GAS from patients, sev-
eral species-specific primers have been designed and
their efficiencies evaluated in previous studies [36–39].
Here we evaluated the use of species-specific primers
to detect the presence of GAS DNA in throat swab sam-
ples from healthy adults based on culture-independent
methods. We tested 148 samples using GAS-specific
primers targeting 16S rRNA and V-Na+-ATPase genes.
The ability of the 16S rRNA V2 region to differentiate
common Staphylococcal and Streptococcal pathogens
was demonstrated by Chakravorty et al. [15], and the V2
region was also used as a marker to identify S. pyogenes,
S. agalactiae and S. pneumoniae in Psoriatic arthritis pa-
tients [40]. Also, a study based on simultaneous detec-
tion of the causative agent of community-acquired
pneumonia demonstrated the reliability of the pathogen-
specific 16S rRNA molecular beacon probe for detection
of GAS [41]. In the Streptococcus genus, V-Na+-ATPase
has only been found in S. pyogenes and S. pneumoniae
[42], and Hung et al. reported the reliability of the V-Na
+-ATPase primer set for GAS identification [27]. The
16S rRNA and V-Na + −ATPase primer sets used in the
present study were validated to ensure their high speci-
ficities and sensitivities and their effectiveness at detect-
ing the small amount of GAS DNA present in the
human throat. Here, the majority of the adults tested
were positive for the presence of GAS DNA (146 of 148,
98.6 %) by PCR screening. The GAS DNA carriage rate
observed in this study is the highest reported for a












emm sequence type 
identified samples
Fig. 4 GAS detection from throat swab samples of healthy adults. a By the culture-dependent method, GAS was isolated from 5 of 148 swab
samples. b By the culture-independent method, the presence of GAS DNA was PCR-confirmed for each sample by PCR with 16S rRNA and V-Na
+-ATPase primers. emm sequence information was acquired from 25 samples. Additional emm type (detected in this study) information is shown































Common types detected from patients in Japan
Culture dependent study
Culture independent study
Fig. 5 Common emm types associated with symptomatic cases (Japan) and emm types detected from healthy people. The common emm types
found in symptomatic patients in Japan and the emm types detected in asymptomatic people (this study) are shown as colored boxes
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participants in the present study belonged to a university
dental faculty they were occupationally associated with
patients, making frequent exposure to GAS via respira-
tory droplets a possibility for them. It will be interesting
for future studies to analyze samples from healthy
people from non-health care settings alongside samples
from health-care professionals. Nevertheless, these re-
sults suggest that culture-independent methods should
be considered when seeking comprehensive understand-
ing of the presence of GAS in healthy hosts.
To be confident about the results obtained by both
detection methods (culture-dependent and culture-
independent), we must contemplate why a detection
rate difference was observed between them. First,
asymptomatic bacterial infections are maintained by a
low replication rate, which controls bacterial growth
and promotes bacterial survival in hostile environ-
ments [3]. Because such populations contain small
numbers of bacteria, it is difficult to isolate them from
commensal-rich environmental samples, while culture-
independent methods can easily detect such popula-
tions. Second, to overcome physicochemical stress in
normal healthy body niches, many pathogens adapt to
a VBNC state (e.g.,Vibrio cholerae and Escherichia coli)
[12]. Previous studies have each revealed the presence
of a small subpopulation of GAS in a VBNC state
under stress conditions [43, 44], and such bacteria are
only traceable by culture-independent methods. Another
possibility that may account for the different detection
rate between the two methods is the presence of GAS in
biofilms, where the hidden population might be difficult
to eradicate post-infection and can remain protected from
host immunity. Such populations make bacterial isolation
difficult, but they can be detected easily by culture-
independent methods [35, 45–47].
However, DNA-based PCR methods cannot distin-
guish between dead and viable bacteria, and this may
lead to overestimation of bacterial numbers [48, 49].
Therefore, with culture-independent methods, we can-
not rule out the presence of residual DNA from recent
bacterial exposure or recurrent pharyngeal GAS carriage.
To confirm the presence of an active population of
asymptomatic GAS would require further evaluation
based on total RNA extraction from throat swab samples
or use of propidium monoazide to distinguish live from
dead bacteria in DNA-based PCR methods [50]. Despite
this issue, our results still shed light on GAS carriage,
and the primers used in this study will be useful for future
analysis of GAS prevalence.
For monitoring GAS strain diversity, an important cell
surface virulence factor, the M-protein encoding emm
gene, has been used successfully over the last two de-
cades, because its hypervariable 5’-end makes it suitable
for this purpose [31]. Therefore identification of emm
types is important for keeping track of the clonal spread
associated with GAS infections. Here, to investigate emm-
type information, we designed a new primer pair and ob-
tained emm sequence information from 16.4 % (25/148)
samples. Interestingly, three samples possessed two differ-
ent emm types, a result rarely reported [51]. In Japan, the
major emm types associated with symptomatic GAS infec-
tions are emm1, emm12, emm4, emm28, and emm75 [52–
55]. Here, we detected emm58, emm106, emm81, and
emm6 types from healthy people. Even though emm58 is
not commonly found in worldwide studies, there are some
reports regarding this emm type in Japan (which is mainly
associated with skin infections) and India [53–57]. These
results indicate that unique emm types might be associ-
ated with GAS carriage in healthy people (Fig. 5).
A major drawback of the emm detection method was
its limited specificity resulting from the emm and/or
emm-like genes that are present in many streptococcal
species [58], as well as the nonspecific amplification of
human DNA in the samples. Although there is clearly a
need to consider removing human DNA from samples
to increase the specificity of this assay, we believe that
our study was partially successful in obtaining emm in-
formation by the culture-independent method, a finding
not reported in earlier PCR-based studies [36, 38–41].
Conclusions
In this study, we investigated the presence of GAS in
throat swab samples from healthy adults in Japan using
culture-dependent and culture-independent methods
using species-specific primers. The GAS isolation rate
was consistent with previous studies; however, culture-
independent detection by conserved GAS-specific primers
confirmed the presence of GAS DNA in the majority of
healthy adults [Fig. 4]. These results suggest that not only
school-age children, but also healthy adults can serve as
GAS carriers. Culture-independent methods should be
considered when seeking comprehensive understanding of
the presence of GAS in healthy hosts. The GAS-specific
primers (16S rRNA and V-Na+-ATPase) used in this study
can be considered useful tools for PCRs aimed at estimat-
ing the maximum potential of GAS carriage in people.
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Additional file 1: Table S1. Samples collected from healthy adults.
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by culture-independent and culture-dependent methods (XLS 48 kb)
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